Jeffrey Bucholtz

Jeffrey Bucholtz

King & Spalding

Contact
View Bio
RSS

Latest Posts › Off-Label Promotion

Share:

FDA Defends Its First Amendment Position in “Memorandum”

On January 18, 2017, the Food and Drug Administration (FDA or the Agency) released for public comment a Memorandum, Public Health Interests and First Amendment Considerations Related to Manufacturer Communications Regarding...more

1/26/2017  /  Draft Guidance , First Amendment , Food and Drug Administration (FDA) , Off-Label Promotion , Pharmaceutical Industry , Public Comment
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide